These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3713925)

  • 21. Non-protein bound iron release during chemotherapy in cancer patients.
    Weijl NI; Elsendoorn TJ; Moison RM; Lentjes EG; Brand R; Berger HM; Osanto S
    Clin Sci (Lond); 2004 May; 106(5):475-84. PubMed ID: 14670072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
    Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
    Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of response to optimize outcome of treatment with erythropoietin.
    Beguin Y
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):27-34. PubMed ID: 9671327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
    Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of cumulative very high dose of cisplatin in chemotherapy resistant solid tumors.
    Tebano MT; Carlini P; Loizzo A; Luzi M; Petrucci F; Alimonti A; Caroli S
    Ann Ist Super Sanita; 1995; 31(3):351-7. PubMed ID: 8712579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron-related indexes in chronic alcoholics. Effect of alcohol withdrawal.
    Conte D; Corsetti M; Colli A; Bardella MT; Cocciolo M; Fraquelli AM
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):534-8. PubMed ID: 9836113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
    Huang CW; Bai L; Cai JJ; Guo W; Lan L
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
    Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of analyzing reticulocyte subpopulations in polycythemia].
    Ataulfo González F; Bermejo A; Sánchez J; Anguita E; Villegas A
    Sangre (Barc); 1997 Oct; 42(5):383-6. PubMed ID: 9424738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
    Khoury H; Adkins D; Brown R; Trinkaus K; Vij R; Miller G; Goodnough LT; DiPersio J
    Bone Marrow Transplant; 2000 Apr; 25(7):737-43. PubMed ID: 10745259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and late hyperferremia during cisplatin chemotherapy.
    Sartori S; Nielsen I; Masotti M; Malacarne P
    J Chemother; 1991 Feb; 3(1):45-50. PubMed ID: 2019863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleologram variations in circulating lymphocytes after chemotherapy.
    Malacarne P; Marzola M; Santini A; Nielsen I
    Folia Biol (Praha); 1986; 32(5):349-53. PubMed ID: 3506525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum iron level in certain neoplastic diseases].
    Kaszewska-Jablońska I
    Pol Arch Med Wewn; 1966; 37(4):395-9. PubMed ID: 5926488
    [No Abstract]   [Full Text] [Related]  

  • 40. [The level of iron in the blood serum in patients with otorhinolaryngologic pathology].
    Khorokh A; Sekretskiĭ R; Semchuk L
    Lab Delo; 1988; (11):76-7. PubMed ID: 2463432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.